Skip to content

A Digitally-Stratified Equitable Symptom Management Intervention on Symptom Burden, Quality of Life and patient activation in Maintenance Hemodialysis Patients: A Randomized Controlled Trial

A Digitally-Stratified Equitable Symptom Management Intervention on Symptom Burden, Quality of Life and patient activation in Maintenance Hemodialysis Patients: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500113977
Enrollment
Unknown
Registered
2025-12-04
Start date
2025-12-06
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End-stage Kidney Disease

Interventions

Trial group:1. Initial assessment and diversion (at enrollment): Assess the patients' digital device usage ability and health information literacy, identify those at risk of "digital divide", and enab
Control group:usual care and health education:Routine symptom management and health education: Nursing content: Routine medical monitoring during dialysis (monitoring vital signs, handling complicatio

Sponsors

The First Affiliated Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Age >= 18 years old. 2.Diagnosed with end-stage renal disease and receiving maintenance hemodialysis treatment for more than 3 months. 3.Clear consciousness, with basic communication and comprehension abilities (able to understand Chinese and have simple conversations). 4.Informed consent has been obtained and a written informed consent form has been voluntarily signed.

Exclusion criteria

Exclusion criteria: 1. Presence of severe cognitive impairment (e.g., due to dementia or serious brain disease), confirmed by clinical assessment or screening with the Mini-Mental State Examination (MMSE) to be unable to comply with study interventions and assessments. 2. Coexistence of severe hearing or visual impairment that cannot be improved by assistive devices (e.g., hearing aids, reading glasses), thereby affecting communication or operational participation in the study. 3. Expected survival time < 6 months, or concurrent participation in other interventional clinical studies that may interfere with the results of this study. 4. Unstable condition, such as occurrence of major clinical events within the past month (e.g., acute myocardial infarction, stroke, or severe infection).

Design outcomes

Primary

MeasureTime frame
Quality of Life;Patient activation scale-13;Adaptive Dialysis Symptom Index;

Secondary

MeasureTime frame
Modified Perceived Social Support Scale, PSSS;Self-Regulatory Fatigue Scale;Coping and Adaptation Processing Scale-Short Form, CAPS-SF;

Countries

China

Contacts

Public ContactBu Qi

Huai'an Fifth People's Hospital

1252742541@qq.com+86 151 5256 2121

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026